Literature DB >> 17714351

Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment.

C Chaussain-Miller1, C Sinding, D Septier, M Wolikow, M Goldberg, M Garabedian.   

Abstract

OBJECTIVE: To evaluate the outcome of 1-(OH) vitamin D and oral phosphate treatment on dentin structure in patients with familial hypophosphatemic rickets, and expression of SIBLINGs (a family of non-collagenous proteins involved in dentinogenesis) and osteocalcin. PATIENTS AND METHODS: Seven patients with familial hypophosphatemic rickets (age 3-16 years) were studied before or during treatment. Deciduous and permanent teeth were prepared for scanning electron microscopy (SEM) analysis and immunohistochemistry.
RESULTS: Untreated or inadequately treated patients had necrotic teeth with impaired dentin mineralization including unmerged calcospherites and accumulation of non-collagenous proteins in wide interglobular spaces. Most of the primary incisors analyzed displayed fissures linking enamel subsurface to pulp horn. These elements may explain the bacterial penetration and dental abscesses despite the absence of carious lesions. Well-treated patients had healthy teeth with good dentin mineralization and little evidence of calcospherites.
CONCLUSION: Treatment of hypophosphatemic children with 1-(OH) vitamin D and oral phosphate insures good dentin development and mineralization, and prevents clinical anomalies such as the dental necrosis classically associated with the disease. Starting treatment during early childhood and good adherence to the therapy are mandatory to observe these beneficial effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714351     DOI: 10.1111/j.1601-0825.2006.01326.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  36 in total

1.  Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex.

Authors:  E Y Chu; H Fong; F A Blethen; K A Tompkins; B L Foster; K D Yeh; K J Nagatomo; D Matsa-Dunn; D Sitara; B Lanske; R B Rutherford; M J Somerman
Journal:  Anat Rec (Hoboken)       Date:  2010-07       Impact factor: 2.064

2.  Conventional Therapy in Adults With XLH Improves Dental Manifestations, But Not Enthesopathy.

Authors:  Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2015-10       Impact factor: 5.958

Review 3.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

4.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

5.  Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease.

Authors:  Jessica Connor; Elizabeth A Olear; Karl L Insogna; Lee Katz; Suher Baker; Raghbir Kaur; Christine A Simpson; John Sterpka; Robert Dubrow; Jane H Zhang; Thomas O Carpenter
Journal:  J Clin Endocrinol Metab       Date:  2015-07-15       Impact factor: 5.958

6.  Dental problems in hypophosphatemic rickets, a cross sectional study.

Authors:  Ali Rabbani; Parisa Rahmani; Vahid Ziaee; Sharareh Ghodoosi
Journal:  Iran J Pediatr       Date:  2012-12       Impact factor: 0.364

Review 7.  Review of the dental implications of X-linked hypophosphataemic rickets (XLHR).

Authors:  Martin M I Sabandal; Peter Robotta; Sebastian Bürklein; Edgar Schäfer
Journal:  Clin Oral Investig       Date:  2015-02-13       Impact factor: 3.573

8.  Dual role of the Trps1 transcription factor in dentin mineralization.

Authors:  Maria Kuzynski; Morgan Goss; Massimo Bottini; Manisha C Yadav; Callie Mobley; Tony Winters; Anne Poliard; Odile Kellermann; Brendan Lee; Jose Luis Millan; Dobrawa Napierala
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

9.  Dental abnormalities and oral health in patients with Hypophosphatemic rickets.

Authors:  Melissa Almeida Souza; Luiz Alberto Valente Soares Junior; Marcela Alves Dos Santos; Maria Helena Vaisbich
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

10.  Dentin noncollagenous matrix proteins in familial hypophosphatemic rickets.

Authors:  Céline Gaucher; Tchilalo Boukpessi; Dominique Septier; Frédéric Jehan; Peter S Rowe; Michèle Garabédian; Michel Goldberg; Catherine Chaussain-Miller
Journal:  Cells Tissues Organs       Date:  2008-08-14       Impact factor: 2.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.